Virtual Reality-Integrated Propulsion Feedback for Stroke Rehab

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Jul 18, 2025

Keywords

ClinConnect Summary

This clinical trial is testing a new way to help people recover their walking ability after a stroke using a combination of virtual reality (VR) and a robotic walking device. The VR system gives real-time visual feedback to encourage the weaker leg to push off more evenly with the stronger leg, which is important for balanced and smooth walking. The goal is to improve how well stroke survivors use their affected leg during walking, which can help them move more naturally and confidently.

The study is open to adults aged 20 and older, including both people who have had a stroke at least one month ago and are able to walk at least 10 meters (about 33 feet) with or without help, as well as healthy adults who can walk on their own. Participants will take part in one session of walking training using the VR and robot system while being carefully monitored for safety, including wearing a heart rate tracker and supported by a saddle-type harness. During the session, researchers will measure how participants walk, how their muscles work, and the pressure on their feet to see if the new system helps improve walking balance and strength. This trial aims to find out if this VR-assisted robot training is a safe and helpful way to support stroke recovery.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults aged 20 years or older.
• * For post-stroke participants:
• • Diagnosis of stroke at least 1 month prior to participation.
• • Able to walk at least 10 meters with or without assistive devices.
• For healthy participants:
• • ° Must walk independently without assistive devices.
• Exclusion Criteria:
• • Individuals with a life expectancy of less than one year.
• • Comatose individuals.
• • Individuals unable to follow three-step commands.
• • Individuals with lower limb amputation.
• • Individuals with poorly controlled diabetes (e.g., foot ulceration).
• • Individuals with legal blindness.
• • Individuals with progressive neurological conditions.
• • Medically unstable individuals.
• • Individuals with significant musculoskeletal impairments.
• • Individuals with congestive heart failure or unstable angina.
• • Individuals with peripheral vascular disease.
• • Individuals with severe neuropsychiatric disorders (e.g., dementia, cognitive deficits, or severe depression).